ORLA CONNEELY to Dihydroergotamine
This is a "connection" page, showing publications ORLA CONNEELY has written about Dihydroergotamine.
Connection Strength
0.761
-
Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia. Leukemia. 2019 01; 33(1):52-63.
Score: 0.594
-
Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors. Sci Rep. 2020 02 18; 10(1):2851.
Score: 0.167